Diabetes alters protein corona to reprogram wear particle–cell interaction
Source abstract
Abstract
The long-term stability of biomedical hard-tissue implants is closely associated with the homeostasis of the surrounding immune microenvironment. Wear particles generated from implants can trigger immune activation, leading to local inflammatory responses and inducing bone destruction, ultimately resulting in implant failure. In addition, in patients with diabetes, chronic metabolic disturbances can disrupt immune homeostasis around implants, thereby increasing the risk of implant-related complications. Although the immunological effects of wear particles under normal physiological conditions have been extensively studied, their behavioral characteristics and immunological effects under metabolic disorder conditions such as diabetes remain insufficiently elucidated. Previous studies have demonstrated that nanoparticles rapidly acquire a protein corona (PC) upon exposure to biological fluids, which determines their immune recognition and interactions with cells. However, how diabetes-associated metabolic abnormalities remodel the PC on wear particles and thereby modulate immune responses has not been fully elucidated. In this study, we found that diabetes induces the formation of a distinct PC, referred to as DM-PC (Diabetic-derived protein corona). The DM-PC was enriched in receptor signaling-related proteins, enhancing interactions between wear particles and macrophage membrane receptors and activating the downstream JAK1-STAT3 pathway. The resulting immune imbalance significantly enhanced particle-induced M1 polarization and osteoclast activation. Collectively, this study proposes a mechanism by which the DM-PC modulates macrophage recognition of wear particles and enhances their inflammatory effects through an inflammation-amplifying signaling axis. These findings provide insight into how diabetes-associated metabolic dysregulation drives the progression of implant complications and offer potential intervention targets for improving the long-term stability of hard-tissue implants in the context of metabolic diseases. STATEMENT OF SIGNIFICANCE: Although the immunological effects of wear particles generated from hard-tissue implants under normal physiological conditions have been extensively investigated, their behavioral characteristics and biological effects in the context of metabolic disorders such as diabetes remain insufficiently elucidated. Given this, from the perspective of the protein corona, this study demonstrates that the diabetic microenvironment alters the interfacial biological properties of wear particles and reshapes their interactions with macrophages, thereby exacerbating inflammatory responses and bone destruction. This study not only elucidates the potential biological basis underlying the increased risk of hard-tissue implant-related complications in patients with diabetes, but also provides mechanistic rationale as well as potential strategies for the prevention or intervention of implant-related complications in diabetic individuals.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Orthopaedic implants and arthroplasty · Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (88)
Show source-provided references
1. A state-of-the-art review of the fabrication and characteristics of titanium and its alloys for biomedical applications10.1007/s42242-021-00170-3 ↗
2. Metallic materials for bone repair
3. Toward a better regeneration through implant-mediated immunomodulation: harnessing the immune responses
4. Osteoimmunomodulation by bone implant materials: harnessing physicochemical properties and chemical composition10.1039/D5BM00357A ↗
5. Potential release of in vivo trace metals from metallic medical implants in the human body: from ions to nanoparticles-a systematic analytical review10.1016/j.actbio.2014.02.027 ↗
6. Prosthetic metals: release, metabolism and toxicity10.2147/IJN.S459255 ↗
7. Emerging factors affecting peri-implant bone metabolism10.1111/prd.12532 ↗
8. Titanium particles in peri-implantitis: distribution, pathogenesis and prospects10.1038/s41368-023-00256-x ↗
9. Roles of inflammatory cell infiltrate in periprosthetic osteolysis10.3389/fimmu.2023.1310262 ↗
10. Obesity/metabolic syndrome and diabetes mellitus on peri-implantitis10.1016/j.tem.2020.05.005 ↗
11. Periodontitis and implant complications in diabetes10.1111/prd.12451 ↗
12. Titanium nanoparticles enhance production and suppress stabilin-1-mediated clearance of GDF-15 in Human primary macrophages10.3389/fimmu.2021.760577 ↗
13. GSK-3β suppression upregulates Gli1 to alleviate osteogenesis inhibition in titanium nanoparticle-induced osteolysis10.1186/s12951-022-01351-7 ↗
14. LncRNA Neat1 promotes the macrophage inflammatory response and acts as a therapeutic target in titanium particle-induced osteolysis10.1016/j.actbio.2022.02.007 ↗
15. Evaluation of the inflammatory and osteogenic response induced by titanium particles released during implantoplasty of dental implants10.1038/s41598-022-20100-2 ↗
16. The crown and the scepter: roles of the protein corona in nanomedicine10.1002/adma.201805740 ↗
17. An overview of nanoparticle protein corona literature
18. Biological features of nanoparticles: protein corona formation and interaction with the immune system10.3390/pharmaceutics14122605 ↗
19. The nanoparticle protein corona impacts interactions with monocytes and macrophages10.1016/j.ijpharm.2025.126518 ↗
20. Formation of the protein corona: the interface between nanoparticles and the immune system10.1016/j.smim.2017.10.001 ↗
21. Protein corona: friend or foe? Co-opting serum proteins for nanoparticle delivery10.1016/j.addr.2022.114635 ↗
22. Disease-related metabolites affect protein-nanoparticle interactions10.1039/C7NR09502C ↗
23. Inflammatory disease progression shapes nanoparticle biomolecular corona-mediated immune activation profiles10.1038/s41467-025-56210-4 ↗
24. The role of patient-specific variables in protein corona formation and therapeutic efficacy in nanomedicine10.1186/s12951-024-02954-y ↗
25. Small molecule modulation of protein corona for deep plasma proteome profiling10.1038/s41467-024-53966-z ↗
26. Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona10.1038/s41565-023-01455-7 ↗
27. Cytotoxic effects of submicron- and nano-scale titanium debris released from dental implants: an integrative review10.1007/s00784-021-03785-z ↗
28. Tracking soluble and nanoparticulated titanium released in vivo from metal dental implant debris using (single-particle)-ICP-MS10.1016/j.jtemb.2023.127143 ↗
29. Release of zirconia nanoparticles at the metal stem-bone cement interface in implant loosening of total hip replacements10.1016/j.actbio.2015.11.044 ↗
30. Direct influence of titanium and zirconia particles on the morphology and functionality of mature human osteoclasts10.1002/jbm.a.36114 ↗
31. Potential role of titanium particles in peri-implantitis: evidence from an integrated clinical, in vivo, and in vitro study10.1016/j.biomaterials.2026.124068 ↗
32. Peri-implantitis
33. Puerarin exerts protective effects on wear particle-induced inflammatory osteolysis10.3389/fphar.2019.01113 ↗
34. Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway10.1186/s12951-021-00915-3 ↗
35. NRF2 is a critical regulator and therapeutic target of metal implant particle-incurred bone damage10.1016/j.biomaterials.2022.121742 ↗
36. Macrophage polarization in aseptic bone resorption around dental implants induced by Ti particles in a murine model10.1111/jre.12633 ↗
37. YTHDF1 transcriptionally activated by TCF4 suppresses osteoblast ferroptosis in titanium nanoparticle-induced osteolysis by accelerating GPX4 and SLC7A11 translation10.1186/s12951-025-03861-6 ↗
38. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest10.1093/nar/gkac1000 ↗
39. Accurate structure prediction of biomolecular interactions with AlphaFold 310.1038/s41586-024-07487-w ↗
40. UniProt: the Universal protein knowledgebase in 202510.1093/nar/gkae1010 ↗
41. PRODIGY: a web server for predicting the binding affinity of protein-protein complexes10.1093/bioinformatics/btw514 ↗
42. The multifaceted roles of macrophages in bone regeneration: a story of polarization, activation and time10.1016/j.actbio.2021.04.052 ↗
43. Macrophages and bone remodeling10.1002/jbmr.4773 ↗
44. Contribution of macrophage polarization in bone metabolism: a literature review10.1016/j.cyto.2024.156768 ↗
45. Mechanistic understanding of protein corona formation around nanoparticles: old puzzles and new insights10.1002/smll.202301663 ↗
46. Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles10.1002/smll.201101511 ↗
47. Biomolecular coronas provide the biological identity of nanosized materials10.1038/nnano.2012.207 ↗
48. Tracing the In vivo fate of nanoparticles with a "non-self" biological identity10.1021/acsnano.0c05178 ↗
49. Systematic identification of allosteric protein-metabolite interactions that control enzyme activity in vivo10.1038/nbt.2489 ↗
50. Redox regulation of macrophages10.1016/j.redox.2024.103123 ↗
51. G protein-coupled receptors in macrophages10.1128/microbiolspec.MCHD-0028-2016 ↗
52. Emerging roles for G-protein coupled receptors in development and activation of macrophages10.3389/fimmu.2019.02031 ↗
53. Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
54. Macrophage plasticity: signaling pathways, tissue repair, and regeneration
55. The JAK-STAT pathway at 30: much learned, much more to do10.1016/j.cell.2022.09.023 ↗
56. Interleukin 6 is significantly increased in severe pneumonia after allo-hematopoietic stem cell transplantation and might induce lung injury via IL-6/sIL-6R/JAK1/STAT3 pathway10.1093/infdis/jiaf041 ↗
57. Modulation of IL-6 receptor/STAT3 downstream signaling in rheumatoid arthritis patients10.1016/j.yexmp.2024.104951 ↗
58. Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases10.1021/jm401490p ↗
59. Immunomodulatory biomaterials for tissue repair10.1021/acs.chemrev.0c00895 ↗
60. Engineering the immune response to biomaterials
61. Role of immune dysregulation in peri-implantitis10.3389/fimmu.2024.1466417 ↗
62. Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes10.1016/j.actbio.2018.04.008 ↗
63. Relationship between diabetes mellitus and periodontal/peri-implant disease: a contemporaneous review10.1016/j.identj.2024.03.010 ↗
64. Diabetes mellitus and hyperglycemia and the risk of aseptic loosening in total joint arthroplasty10.1016/j.arth.2017.02.056 ↗
65. Chronic hyperglycemia as a risk factor in implant therapy10.1111/prd.12283 ↗
66. Diabetes mellitus and dental implants: a systematic review and meta-analysis10.3390/ma15093227 ↗
67. Lithium chloride with immunomodulatory function for regulating titanium nanoparticle-stimulated inflammatory response and accelerating osteogenesis through suppression of MAPK signaling pathway10.2147/IJN.S210834 ↗
68. Britanin inhibits titanium wear particle-induced osteolysis and osteoclastogenesis10.3892/mmr.2023.13092 ↗
69. NOX4 blockade suppresses titanium nanoparticle-induced bone destruction via activation of the Nrf2 signaling pathway10.1186/s12951-022-01413-w ↗
70. Macrophages in aseptic loosening: characteristics, functions, and mechanisms10.3389/fimmu.2023.1122057 ↗
71. Corona of thorns: the surface chemistry-mediated protein Corona perturbs the recognition and immune response of macrophages10.1021/acsami.9b15910 ↗
72. Mediation of osseointegration, osteoimmunology, and osteoimmunologic integration by tregs and macrophages: a narrative review10.3390/ijms26115421 ↗
73. Osteoimmune regulation in dental implant osseointegration: from foreign body response to therapeutic immunomodulation–a narrative review
74. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: a critical review10.1016/j.ijbiomac.2020.12.108 ↗
75. The protein corona from nanomedicine to environmental science
76. Physiological pH transition-driven protein corona dynamics regulate cellular uptake and inflammatory responses of silica nanoparticles
77. Cell-cell communication: new insights and clinical implications10.1038/s41392-024-01888-z ↗
78. G protein-coupled and membrane tyrosine kinase receptor relationships yield therapeutic opportunities10.1210/endrev/bnaf019 ↗
79. The JAK-STAT pathway: from structural biology to cytokine engineering10.1038/s41392-024-01934-w ↗
80. JAK: not just another Kinase10.1158/1535-7163.MCT-22-0323 ↗
81. Magnetic responsive hydroxyapatite scaffold modulated macrophage polarization through PPAR/JAK-STAT signaling and enhanced fatty acid metabolism10.1016/j.biomaterials.2023.122051 ↗
82. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases10.1002/jcp.30375 ↗
83. JAK/STAT signaling pathway affects CCR5 expression in human CD4+ T cells10.1126/sciadv.adl0368 ↗
84. Local cellular responses to metallic and ceramic nanoparticles from orthopedic Joint arthroplasty implants10.2147/IJN.S248848 ↗
85. Effect of adsorbed proteins on the wettability of hydrophilic and hydrophobic solids10.1038/196476a0 ↗
86. The effects of protein corona on in vivo fate of nanocarriers10.1016/j.addr.2022.114356 ↗
87. In situ analysis for protein corona: from morphology, composition, structure to dynamic process10.1002/smtd.202500348 ↗
88. Debugging the dynamics of protein corona: formation, composition, challenges, and applications at the nano-bio interface10.1016/j.cis.2025.103535 ↗